ArticleFrontiers in oncology2026
Case Report: Life-saving emergency chemotherapy in a critically ill patient with suspected metastatic testicular cancer prior to histological confirmation.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Patients with metastatic germ cell tumors undergo therapy including orchiectomy, chemotherapy and residual tumor resection. Even in case of metastatic disease, the treatment is still administered with curative intent. We present a case in which chemotherapy was successfully applied in an emergency setting prior to having histological confirmation of the suspected diagnosis of a germ cell tumor on our intensive care unit (ICU) while the patient was requiring mechanical ventilation, continuous renal replacement therapy (CRRT) and vasopressor support. Case presentation: A 35-year-old man presented with massive testicular swelling, severe dyspnea, bilateral leg edema and acute postrenal kidney failure. A computed tomography (CT) scan revealed extensive pulmonary and retroperitoneal metastases and pneumonia. He was admitted to our intensive care unit with multiorgan dysfunction requiring mechanical ventilation, CRRT and vasopressor support. Laboratory findings revealed moderately elevated beta-human chorionic gonadotropin (570 mIU/ml) and an elevated lactate dehydrogenase over 2000 U/L. Due to his critical condition and high clinical suspicion of a metastatic germ cell tumor, chemotherapy according to the PEI regimen (cisplatin, etoposide, ifosfamide) was initiated only one day after the admission to our ICU before histological confirmation of the diagnosis. The patient showed marked clinical, laboratory and radiological improvement after one cycle. An orchiectomy later revealed necrotic tissue with residual seminoma. Subsequent cycles required dose reductions due to prolonged kidney failure, infectious complications during aplasia and cardiomyopathy leading to heart failure. Application of ifosfamide was discontinued after the patient suffered from severe ifosfamide-related toxicities, including Fanconi-syndrome and neurotoxicity. A Positron Emission Tomography-CT scan after four cycles demonstrated an overall regression of the tumor with residual lesions. Conclusion: Advanced testicular cancer can present as an acute emergency. In selected life-threatening situations, immediate chemotherapy is justified in patients with high clinical suspicion of a germ cell tumor, even in the absence of histological confirmation. The combination of clinical findings, the pattern of metastases, morphological findings in imaging and tumor markers should be used to define the most likely diagnosis beforehand.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.